NCT04330586View on ClinicalTrials.gov

A Trial of Ciclesonide in Adults With Mild-to-moderate COVID-19

PHASE2CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

April 1, 2020

Primary Completion Date

March 31, 2021

Study Completion Date

March 31, 2021

Conditions
COVID-19
Interventions
DRUG

Ciclesonide Metered Dose Inhaler [Alvesco]

Ciclesonide 320ug oral inhalation q12h for 14 days

Trial Locations (1)

Unknown

Korea University Guro Hospital, Seoul

All Listed Sponsors
lead

Korea University Guro Hospital

OTHER

NCT04330586 - A Trial of Ciclesonide in Adults With Mild-to-moderate COVID-19 | Biotech Hunter | Biotech Hunter